Document is current

Article History

Received: 8 June 2018

Accepted: 19 August 2018

First Online: 22 October 2018

Ethics approval and consent to participate

: The study was approved by an internal commission of physicians working in the Department of “Hematology and cellular Biotechnology”, Univ. “Sapienza”, Rome, Italy. All patients enrolled in our study were informed on the treatment characteristics and they signed an informed consent.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.